Dr. Mark Cooper

Dr. Mark Cooper (DR. MARK COOPER ) is A Dentist Physician in Chester, NY. The NPI Number for Dr. Mark Cooper is 1730359449.

The current location address for Dr. Mark Cooper is 11 WEST AVE ROUTE 94 Chester, NY 10918 and the contact number is 8454697040 and fax number is . The mailing address for Dr. Mark Cooper is 11 WEST AVE ROUTE 94 Chester, NY 10918- 8454697040 (mailing address contact number - 8454697040).

A dentist is a person qualified by a doctorate in dental surgery (D.D.S.) or dental medicine (D.M.D.), licensed by the state to practice dentistry, and practicing within the scope of that license. There is no difference between the two degrees: dentists who have a DMD or DDS have the same education. Universities have the prerogative to determine what degree is awarded. Both degrees use the same curriculum requirements set by the American Dental Association's Commission on Dental Accreditation. Generally, three or more years of undergraduate education plus four years of dental school is required to graduate and become a general dentist. State licensing boards accept either degree as equivalent, and both degrees allow licensed individuals to practice the same scope of general dentistry. Additional post-graduate training is required to become a dental specialist.

What is the NPI Number for Dr. Mark Cooper ?

Answer: The NPI Number for Dr. Mark Cooper is 1730359449

Where is Dr. Mark Cooper located?

Answer: Dr. Mark Cooper is located at 11 WEST AVE ROUTE 94 Chester, NY 10918.

What is the specialty for Dr. Mark Cooper ?

Answer: The Specialty of Dr. Mark Cooper is A Dentist Physician.

Are there any online reviews for Dr. Mark Cooper ?

Answer: Yes! Check It Now.

Are there any other health care providers in Chester, NY?

Answer: Yes, there are given below...

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type	Dentist
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills	27
Number of Standardized 30-Day Fills	31
Aggregate Cost Paid for All Claims	140.37
Number of Day's Supply for All Claims	307
Number of Medicare Beneficiaries	18
Number of Claims, Including Refills, for Beneficiaries Age 65+	27
Including Refills, for Beneficiaries Age 65+	31
Beneficiaries Age 65+	140.37
Number of Day's Supply for All Claims for Beneficaries Age 65+	307
Number of Medicare Beneficiaries Age 65+	18
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst	#
Total Claims of Brand-Name Drugs
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills	25
Aggregate Cost Paid for Generic Drugs	128.03
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst	*
Total Claims of Other Drugs, Including Refills
Aggregate Cost Paid for Other Drugs
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst	*
Number of Claims for Beneficiaries Covered by MAPD Plans
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst	#
Number of Claims for Beneficiaries Covered by Standalone PDP Plans
Aggregate Cost Paid for Claims Filled by
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst	*
Number of Claims for Beneficiaries Covered by Low-Income Subsidy
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst	#
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy
by Low-Income Subsidy
Total Claims of Opioid Drugs, Including	0
Aggregate Cost Paid for Opioid Drugs	0
Opioid Claims	0
Opioid_Tot_Clms divided by the Tot_Clms	0
Total Claims of Long-Acting Opioid Drugs	0
Aggregate Cost Paid for Long-Acting Opioid	0
Number of Day's Supply of All Long-Acting	0
Long-Acting Opioid Claims	0
Opioid_LA_Tot_Clms divided by the
Total Claims of Antibiotic Drugs, Including	24
Aggregate Cost Paid for Antibiotic Drugs	64.35
Antibiotic Claims	17
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst
Including Refills, for Beneficiaries Age 65+	0
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+	0
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims	0
Average Age of Beneficiaries	76.055555556
Number of Beneficiaries Age Less Than 65	0
Number of Beneficiaries Age 65 to 74
Number of Beneficiaries Age 75 to 84
Number of Female Beneficiaries
Number of Male Beneficiaries
Number of Non-Hispanic White	13
Number of Black or African American
Number of Asian Pacific Islander
Number of Hispanic Beneficiaries
Number of American Indian/Alaskan NativeBeneficiaries	0
Number of Beneficiaries with Race Not
Only Entitlement
Average Hierarchical Condition Category	1.5861111111